<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/tpj/journal/vaop/ncurrent/rss.rdf">
<title>The Pharmacogenomics Journal</title>
<description/>
<link>http://www.nature.com/tpj/journal/vaop/ncurrent/rss.rdf</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>
Copyright &#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:issn>1470-269X</prism:issn>
<prism:copyright>
Copyright &#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/tpj.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/sj.tpj.6500491"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.10"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.11"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.12"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.13"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.15"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.16"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.17"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.18"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.2"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.4"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.5"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2008.7"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/tpj.gif">
<title>The Pharmacogenomics Journal</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/tpj.gif</url>
<link>http://www.nature.com/tpj/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/sj.tpj.6500491">
<title>Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy</title>
<link>http://dx.doi.org/10.1038/sj.tpj.6500491</link>
<content:encoded><![CDATA[

<p>
<b>Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, February 5, 2008. <a href="http://dx.doi.org/10.1038/sj.tpj.6500491">doi:10.1038/sj.tpj.6500491</a>
</p>
<p>Authors: M J V Wilkie, G Smith, R K Day, K Matthews, D Smith, D Blackwood, I C Reid
&amp; C R Wolf</p>
]]></content:encoded>
<dc:title>Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy</dc:title>
<dc:creator>M J V Wilkie</dc:creator>
<dc:creator>G Smith</dc:creator>
<dc:creator>R K Day</dc:creator>
<dc:creator>K Matthews</dc:creator>
<dc:creator>D Smith</dc:creator>
<dc:creator>D Blackwood</dc:creator>
<dc:creator>I C Reid</dc:creator>
<dc:creator>C R Wolf</dc:creator>
<dc:identifier>doi:10.1038/sj.tpj.6500491</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, February 5, 2008</dc:source>
<dc:date>February 5, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>February 5, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.10">
<title>Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials</title>
<link>http://dx.doi.org/10.1038/tpj.2008.10</link>
<content:encoded><![CDATA[

<p>
<b>Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, September 9, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.10">doi:10.1038/tpj.2008.10</a>
</p>
<p>Authors: G R Uhl, T Drgon, C Johnson
&amp; J E Rose</p>
]]></content:encoded>
<dc:title>Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials</dc:title>
<dc:creator>G R Uhl</dc:creator>
<dc:creator>T Drgon</dc:creator>
<dc:creator>C Johnson</dc:creator>
<dc:creator>J E Rose</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.10</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, September 9, 2008</dc:source>
<dc:date>September 9, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>September 9, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.11">
<title>Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group</title>
<link>http://dx.doi.org/10.1038/tpj.2008.11</link>
<content:encoded><![CDATA[

<p>
<b>Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, September 16, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.11">doi:10.1038/tpj.2008.11</a>
</p>
<p>Authors: C M Bromley, S Close, N Cohen, R Favis, B Fijal, F Gheyas, W Liu, C Lopez-Correa, A Prokop, J B Singer, A Snapir, A Tchelet, D Wang
&amp; D Goldstaub</p>
]]></content:encoded>
<dc:title>Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group</dc:title>
<dc:creator>C M Bromley</dc:creator>
<dc:creator>S Close</dc:creator>
<dc:creator>N Cohen</dc:creator>
<dc:creator>R Favis</dc:creator>
<dc:creator>B Fijal</dc:creator>
<dc:creator>F Gheyas</dc:creator>
<dc:creator>W Liu</dc:creator>
<dc:creator>C Lopez-Correa</dc:creator>
<dc:creator>A Prokop</dc:creator>
<dc:creator>J B Singer</dc:creator>
<dc:creator>A Snapir</dc:creator>
<dc:creator>A Tchelet</dc:creator>
<dc:creator>D Wang</dc:creator>
<dc:creator>D Goldstaub</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.11</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, September 16, 2008</dc:source>
<dc:date>September 16, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>September 16, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.12">
<title>Personalized medicine: are we there yet?</title>
<link>http://dx.doi.org/10.1038/tpj.2008.12</link>
<content:encoded><![CDATA[

<p>
<b>Personalized medicine: are we there yet?</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, September 16, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.12">doi:10.1038/tpj.2008.12</a>
</p>
<p>Author: O N Ikediobi</p>
]]></content:encoded>
<dc:title>Personalized medicine: are we there yet?</dc:title>
<dc:creator>O N Ikediobi</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.12</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, September 16, 2008</dc:source>
<dc:date>September 16, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>September 16, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.13">
<title>Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans</title>
<link>http://dx.doi.org/10.1038/tpj.2008.13</link>
<content:encoded><![CDATA[

<p>
<b>Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, September 30, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.13">doi:10.1038/tpj.2008.13</a>
</p>
<p>Authors: M A Perera, R K Thirumaran, N J Cox, S Hanauer, S Das, C Brimer-Cline, V Lamba, E G Schuetz, M J Ratain
&amp; A Di Rienzo</p>
]]></content:encoded>
<dc:title>Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans</dc:title>
<dc:creator>M A Perera</dc:creator>
<dc:creator>R K Thirumaran</dc:creator>
<dc:creator>N J Cox</dc:creator>
<dc:creator>S Hanauer</dc:creator>
<dc:creator>S Das</dc:creator>
<dc:creator>C Brimer-Cline</dc:creator>
<dc:creator>V Lamba</dc:creator>
<dc:creator>E G Schuetz</dc:creator>
<dc:creator>M J Ratain</dc:creator>
<dc:creator>A Di Rienzo</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.13</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, September 30, 2008</dc:source>
<dc:date>September 30, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>September 30, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.15">
<title>The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice</title>
<link>http://dx.doi.org/10.1038/tpj.2008.15</link>
<content:encoded><![CDATA[

<p>
<b>The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, October 28, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.15">doi:10.1038/tpj.2008.15</a>
</p>
<p>Authors: R H Bonow, S A&#239;d, Y Zhang, K G Becker
&amp; F Bosetti</p>
]]></content:encoded>
<dc:title>The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice</dc:title>
<dc:creator>R H Bonow</dc:creator>
<dc:creator>S A&#239;d</dc:creator>
<dc:creator>Y Zhang</dc:creator>
<dc:creator>K G Becker</dc:creator>
<dc:creator>F Bosetti</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.15</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, October 28, 2008</dc:source>
<dc:date>October 28, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>October 28, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.16">
<title>Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer</title>
<link>http://dx.doi.org/10.1038/tpj.2008.16</link>
<content:encoded><![CDATA[

<p>
<b>Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, December 23, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.16">doi:10.1038/tpj.2008.16</a>
</p>
<p>Authors: F Graziano, A Ruzzo, E Canestrari, F Loupakis, D Santini, E Rulli, B Humar, N Galluccio, R Bisonni, I Floriani, P Maltese, A Falcone, G Tonini, V Catalano, A Fontana, L Giustini, G Masi, B Vincenzi, P Alessandroni
&amp; M Magnani</p>
]]></content:encoded>
<dc:title>Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer</dc:title>
<dc:creator>F Graziano</dc:creator>
<dc:creator>A Ruzzo</dc:creator>
<dc:creator>E Canestrari</dc:creator>
<dc:creator>F Loupakis</dc:creator>
<dc:creator>D Santini</dc:creator>
<dc:creator>E Rulli</dc:creator>
<dc:creator>B Humar</dc:creator>
<dc:creator>N Galluccio</dc:creator>
<dc:creator>R Bisonni</dc:creator>
<dc:creator>I Floriani</dc:creator>
<dc:creator>P Maltese</dc:creator>
<dc:creator>A Falcone</dc:creator>
<dc:creator>G Tonini</dc:creator>
<dc:creator>V Catalano</dc:creator>
<dc:creator>A Fontana</dc:creator>
<dc:creator>L Giustini</dc:creator>
<dc:creator>G Masi</dc:creator>
<dc:creator>B Vincenzi</dc:creator>
<dc:creator>P Alessandroni</dc:creator>
<dc:creator>M Magnani</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.16</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, December 23, 2008</dc:source>
<dc:date>December 23, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>December 23, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.17">
<title>A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies</title>
<link>http://dx.doi.org/10.1038/tpj.2008.17</link>
<content:encoded><![CDATA[

<p>
<b>A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, December 23, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.17">doi:10.1038/tpj.2008.17</a>
</p>
<p>Authors: Y Sato, N M Laird, K Nagashima, R Kato, T Hamano, A Yafune, N Kaniwa, Y Saito, E Sugiyama, S-R Kim, J Furuse, H Ishii, H Ueno, T Okusaka, N Saijo, J-i Sawada
&amp; T Yoshida</p>
]]></content:encoded>
<dc:title>A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies</dc:title>
<dc:creator>Y Sato</dc:creator>
<dc:creator>N M Laird</dc:creator>
<dc:creator>K Nagashima</dc:creator>
<dc:creator>R Kato</dc:creator>
<dc:creator>T Hamano</dc:creator>
<dc:creator>A Yafune</dc:creator>
<dc:creator>N Kaniwa</dc:creator>
<dc:creator>Y Saito</dc:creator>
<dc:creator>E Sugiyama</dc:creator>
<dc:creator>S-R Kim</dc:creator>
<dc:creator>J Furuse</dc:creator>
<dc:creator>H Ishii</dc:creator>
<dc:creator>H Ueno</dc:creator>
<dc:creator>T Okusaka</dc:creator>
<dc:creator>N Saijo</dc:creator>
<dc:creator>J-i Sawada</dc:creator>
<dc:creator>T Yoshida</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.17</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, December 23, 2008</dc:source>
<dc:date>December 23, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>December 23, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.18">
<title>Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees</title>
<link>http://dx.doi.org/10.1038/tpj.2008.18</link>
<content:encoded><![CDATA[

<p>
<b>Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, December 16, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.18">doi:10.1038/tpj.2008.18</a>
</p>
<p>Authors: R Dal-R&#233;, I Luque, R Torres
&amp; J Lahuerta</p>
]]></content:encoded>
<dc:title>Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees</dc:title>
<dc:creator>R Dal-R&#233;</dc:creator>
<dc:creator>I Luque</dc:creator>
<dc:creator>R Torres</dc:creator>
<dc:creator>J Lahuerta</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.18</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, December 16, 2008</dc:source>
<dc:date>December 16, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>December 16, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.2">
<title>Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives</title>
<link>http://dx.doi.org/10.1038/tpj.2008.2</link>
<content:encoded><![CDATA[

<p>
<b>Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, March 4, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.2">doi:10.1038/tpj.2008.2</a>
</p>
<p>Authors: P E H Schwarz, G W Towers, A van der Merwe, L Perez-Perez, P Rheeder, J Schulze, S R Bornstein, J Licinio, M-L Wong, A E Schutte
&amp; A Olckers</p>
]]></content:encoded>
<dc:title>Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives</dc:title>
<dc:creator>P E H Schwarz</dc:creator>
<dc:creator>G W Towers</dc:creator>
<dc:creator>A van der Merwe</dc:creator>
<dc:creator>L Perez-Perez</dc:creator>
<dc:creator>P Rheeder</dc:creator>
<dc:creator>J Schulze</dc:creator>
<dc:creator>S R Bornstein</dc:creator>
<dc:creator>J Licinio</dc:creator>
<dc:creator>M-L Wong</dc:creator>
<dc:creator>A E Schutte</dc:creator>
<dc:creator>A Olckers</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.2</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, March 4, 2008</dc:source>
<dc:date>March 4, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>March 4, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.4">
<title>Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions</title>
<link>http://dx.doi.org/10.1038/tpj.2008.4</link>
<content:encoded><![CDATA[

<p>
<b>Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, February 26, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.4">doi:10.1038/tpj.2008.4</a>
</p>
<p>Authors: M R Nelson, S-A Bacanu, M Mosteller, L Li, C E Bowman, A D Roses, E H Lai
&amp; M G Ehm</p>
]]></content:encoded>
<dc:title>Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions</dc:title>
<dc:creator>M R Nelson</dc:creator>
<dc:creator>S-A Bacanu</dc:creator>
<dc:creator>M Mosteller</dc:creator>
<dc:creator>L Li</dc:creator>
<dc:creator>C E Bowman</dc:creator>
<dc:creator>A D Roses</dc:creator>
<dc:creator>E H Lai</dc:creator>
<dc:creator>M G Ehm</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.4</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, February 26, 2008</dc:source>
<dc:date>February 26, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>February 26, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.5">
<title>DRD4 48&#8201;bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain</title>
<link>http://dx.doi.org/10.1038/tpj.2008.5</link>
<content:encoded><![CDATA[

<p>
<b>DRD4 48&#8201;bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, March 11, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.5">doi:10.1038/tpj.2008.5</a>
</p>
<p>Authors: J Popp, S Leucht, S Heres
&amp; W Steimer</p>
]]></content:encoded>
<dc:title>DRD4 48&#8201;bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain</dc:title>
<dc:creator>J Popp</dc:creator>
<dc:creator>S Leucht</dc:creator>
<dc:creator>S Heres</dc:creator>
<dc:creator>W Steimer</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.5</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, March 11, 2008</dc:source>
<dc:date>March 11, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>March 11, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2008.7">
<title>The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction</title>
<link>http://dx.doi.org/10.1038/tpj.2008.7</link>
<content:encoded><![CDATA[

<p>
<b>The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction</b>
</p>
<p>The Pharmacogenomics Journal advance online publication, July 1, 2008. <a href="http://dx.doi.org/10.1038/tpj.2008.7">doi:10.1038/tpj.2008.7</a>
</p>
<p>Authors: M C Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, J Chabert, P Dayer, D Hochstrasser
&amp; M F Rossier</p>
]]></content:encoded>
<dc:title>The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction</dc:title>
<dc:creator>M C Rebsamen</dc:creator>
<dc:creator>J Desmeules</dc:creator>
<dc:creator>Y Daali</dc:creator>
<dc:creator>A Chiappe</dc:creator>
<dc:creator>A Diemand</dc:creator>
<dc:creator>C Rey</dc:creator>
<dc:creator>J Chabert</dc:creator>
<dc:creator>P Dayer</dc:creator>
<dc:creator>D Hochstrasser</dc:creator>
<dc:creator>M F Rossier</dc:creator>
<dc:identifier>doi:10.1038/tpj.2008.7</dc:identifier>
<dc:source>The Pharmacogenomics Journal advance online publication, July 1, 2008</dc:source>
<dc:date>July 1, 2008</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>July 1, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
</rdf:RDF>
